BIOMAT Database Logo BIOMAT Database Logo

Dual-protected amino acid derivatives as new antitubercular agents. 2018

Pedro P de Castro, and Débora L Campos, and Fernando R Pavan, and Giovanni W Amarante
Department of Chemistry, Federal University of Juiz de Fora, Minas Gerais, Brazil.

Tuberculosis is an infectious disease with high incidence and growing drug-resistant rates. In an attempt to develop new antitubercular agents, 35 compounds were synthesized, most of them bearing a carbamate and enantiopure amino acid moiety. These compounds had their activity evaluated toward a Mycobacterium tuberculosis strain (ATCC 27294) and cytotoxicity against fibroblast MRC-5 cells (ATCC CCL-171). Three of the prepared derivatives presented a good antimicrobial inhibition and two of them a moderate cytotoxicity. The lipophilicity seems to play a vital role in the cell growth activity, with best results for the derivatives with a higher logP.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000596 Amino Acids Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. Amino Acid,Acid, Amino,Acids, Amino
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Pedro P de Castro, and Débora L Campos, and Fernando R Pavan, and Giovanni W Amarante
Brønsted Acid-Catalyzed Epimerization-Free Preparation of Dual-Protected Amino Acid Derivatives.
June 2017, ACS omega,
Pedro P de Castro, and Débora L Campos, and Fernando R Pavan, and Giovanni W Amarante
Amino acid derivatives of ligustrazine-oleanolic acid as new cytotoxic agents.
November 2014, Molecules (Basel, Switzerland),
Pedro P de Castro, and Débora L Campos, and Fernando R Pavan, and Giovanni W Amarante
Identification of Better Pharmacokinetic Benzothiazinone Derivatives as New Antitubercular Agents.
June 2017, ACS medicinal chemistry letters,
Pedro P de Castro, and Débora L Campos, and Fernando R Pavan, and Giovanni W Amarante
[Evaluation of new antitubercular agents--new rifamycin derivatives].
October 1992, Kekkaku : [Tuberculosis],
Pedro P de Castro, and Débora L Campos, and Fernando R Pavan, and Giovanni W Amarante
Vinca-23-oyl amino acid derivatives: as new anticancer agents (review).
January 1985, Anticancer research,
Pedro P de Castro, and Débora L Campos, and Fernando R Pavan, and Giovanni W Amarante
Design, synthesis, and computational studies of benzimidazole derivatives as new antitubercular agents.
April 2023, Journal of biomolecular structure & dynamics,
Pedro P de Castro, and Débora L Campos, and Fernando R Pavan, and Giovanni W Amarante
Synthesis of glycosylated beta-amino acids as new class of antitubercular agents.
September 2002, European journal of medicinal chemistry,
Pedro P de Castro, and Débora L Campos, and Fernando R Pavan, and Giovanni W Amarante
New hydroxamic acids as antitubercular agents.
November 1952, Nature,
Pedro P de Castro, and Débora L Campos, and Fernando R Pavan, and Giovanni W Amarante
Synthesis and antitubercular activity of novel amino acid derivatives.
February 2012, Chemical biology & drug design,
Pedro P de Castro, and Débora L Campos, and Fernando R Pavan, and Giovanni W Amarante
Synthesis of functionalized amino acid derivatives as new pharmacophores for designing anticancer agents.
June 2009, Journal of enzyme inhibition and medicinal chemistry,
Copied contents to your clipboard!